Smalley, Keiran S. M.
Eroglu, Zeynep
Sondak, Vernon K.
Funding for this research was provided by:
National Cancer Institute (CA168536, CA161107, R21 CA198550)
Article History
First Online: 10 February 2016
Compliance with Ethical Standards
: This work was supported by R01 CA161107-01, R21 CA198550, and SPORE grant CA168536 from the National Institutes of Health. Vernon K Sondak has served as a consultant to BMS, GSK, Merck, Novartis, OncoSec, Genentech/Roche, Navidea, Amgen, and Provectus. Keiran SM Smalley and Zeynep Eroglu declare no conflicts of interest.